Multi Cancer Early Detection by Using Circulating Tumor DNA—The Galleri Test. Reply to Klein et al. The Promise of Multicancer Early Detection. Comment on “Pons-Belda et al. Can Circulating Tumor DNA Support a Successful Screening Test for Early Cancer Detection? The Grail Paradigm. Diagnostics 2021, 11, 2171”

We recently published some concerns with new technologies which are based on circulating tumor DNA (ctDNA) for early cancer detection. Most of our published criticism, including a commentary in this journal, has focused on tests developed by the biotechnology company GRAIL (their commercial product...

Descripción completa

Detalles Bibliográficos
Autores principales: Pons-Belda, Oscar D., Fernandez-Uriarte, Amaia, Diamandis, Eleftherios P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Reply
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9141547/
https://www.ncbi.nlm.nih.gov/pubmed/35626399
http://dx.doi.org/10.3390/diagnostics12051244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9141547/
https://www.ncbi.nlm.nih.gov/pubmed/35626399
http://dx.doi.org/10.3390/diagnostics12051244

Ejemplares similares